IL134792A0 - Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists - Google Patents

Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists

Info

Publication number: IL134792A0
Authority: IL; Israel
Prior art keywords: agonists; aromatic; substituted tetrahydro; prostaglandins useful; tetrahydro prostaglandins
Prior art date: 1997-09-09

Application number

IL13479298A

Other languages

English (en)

Original Assignee

Procter & Gamble

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-09-09

Filing date

1998-09-04

Publication date

2001-04-30

1998-09-04 Application filed by Procter & Gamble filed Critical Procter & Gamble

2001-04-30 Publication of IL134792A0 publication Critical patent/IL134792A0/xx

Links

239000000556 agonist Substances 0.000 title 1
125000003118 aryl group Chemical group 0.000 title 1
229940094443 oxytocics prostaglandins Drugs 0.000 title 1
150000003180 prostaglandins Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Physical Education & Sports Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Ophthalmology & Optometry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)

IL13479298A 1997-09-09 1998-09-04 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists IL134792A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US5824697P	1997-09-09	1997-09-09
PCT/US1998/018340 WO1999012896A1 (fr)	1997-09-09	1998-09-04	Prostaglandines aromatiques tetrahydro substituees par c16-c20 utilisees comme agonistes fp

Publications (1)

Publication Number	Publication Date
IL134792A0 true IL134792A0 (en)	2001-04-30

Family

ID=22015602

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL13479298A IL134792A0 (en)	1997-09-09	1998-09-04	Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists

Country Status (23)

Country	Link
US (1)	US6107338A (fr)
EP (1)	EP1021402B1 (fr)
JP (1)	JP2001515883A (fr)
KR (1)	KR20010023837A (fr)
CN (1)	CN1269785A (fr)
AR (1)	AR017077A1 (fr)
AT (1)	ATE310721T1 (fr)
AU (1)	AU741014B2 (fr)
BR (1)	BR9811779A (fr)
CA (1)	CA2303763C (fr)
CO (1)	CO4970730A1 (fr)
DE (1)	DE69832513T2 (fr)
ES (1)	ES2253826T3 (fr)
HU (1)	HUP0004436A3 (fr)
IL (1)	IL134792A0 (fr)
NO (1)	NO20001142L (fr)
NZ (1)	NZ503736A (fr)
PE (1)	PE123199A1 (fr)
PL (1)	PL339213A1 (fr)
SK (1)	SK3362000A3 (fr)
TR (1)	TR200000670T2 (fr)
WO (1)	WO1999012896A1 (fr)
ZA (1)	ZA988231B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1114816A4 (fr) *	1998-09-14	2002-09-04	Ono Pharmaceutical Co	DERIVES E DE PHENYL-PROSTAGLANDINE A SUBSTITUTION-$g(V) ET MEDICAMENTS LES CONTENANT COMME INGREDIENT ACTIF
WO2000051980A1 (fr)	1999-03-05	2000-09-08	The Procter & Gamble Company	Analogues de prostaglandines c16 fp selectives insaturees
US6894175B1 (en)	1999-08-04	2005-05-17	The Procter & Gamble Company	2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
EP1202999B1 (fr) *	1999-08-04	2003-06-18	The Procter & Gamble Company	Nouveaux analogues 2-decarboxy-2-phosphinico prostaglandine f
US20020037914A1 (en) *	2000-03-31	2002-03-28	Delong Mitchell Anthony	Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en)	2000-03-31	2002-11-21	Delong Michell Anthony	Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en)	2000-03-31	2002-01-31	Delong Mitchell Anthony	Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US6586462B2 (en)	2000-10-20	2003-07-01	Allergan, Inc.	ω-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists
US6376533B1 (en) *	2000-10-20	2002-04-23	Allergan Sales, Inc.	Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists
US6531504B2 (en) *	2001-05-17	2003-03-11	Allergan, Inc.	Prostanoic acid derivatives as agents for lowering intraocular pressure
US7631336B2 (en)	2004-07-30	2009-12-08	Broadband Itv, Inc.	Method for converting, navigating and displaying video content uploaded from the internet to a digital TV video-on-demand platform
US7590997B2 (en)	2004-07-30	2009-09-15	Broadband Itv, Inc.	System and method for managing, converting and displaying video content on a video-on-demand platform, including ads used for drill-down navigation and consumer-generated classified ads
WO2006047466A2 (fr) *	2004-10-21	2006-05-04	Duke University	Medicaments ophtalmologiques
US20070254920A1 (en) *	2006-04-26	2007-11-01	Aerie Pharmaceuticals, Inc.	Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
US8455513B2 (en)	2007-01-10	2013-06-04	Aerie Pharmaceuticals, Inc.	6-aminoisoquinoline compounds
US8450344B2 (en)	2008-07-25	2013-05-28	Aerie Pharmaceuticals, Inc.	Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
EP2349242B1 (fr)	2008-10-29	2018-12-05	Novaer Holdings, Inc.	Sels d'acides aminés de prostaglandines
US8722739B2 (en)	2008-10-29	2014-05-13	Novaer Holdings, Inc.	Amino acid salts of prostaglandins
US8623918B2 (en) *	2008-10-29	2014-01-07	Novaer Holdings, Inc.	Amino acid salts of prostaglandins
US20110293549A1 (en)	2009-02-03	2011-12-01	Athena Cosmetics, Inc.	Composition, method and kit for enhancing hair
ES2834451T3 (es)	2009-05-01	2021-06-17	Aerie Pharmaceuticals Inc	Inhibidores de mecanismo doble para el tratamiento de enfermedades
AU2012326361B2 (en)	2011-10-17	2017-08-03	Biotheryx, Inc.	Substituted biaryl alkyl amides
EP2976080B1 (fr)	2013-03-15	2019-12-25	Aerie Pharmaceuticals, Inc.	Conjugés de composés isoquinoline et de prostaglandines
CN104140410B (zh) *	2013-05-09	2017-12-15	江苏豪森药业集团有限公司	鲁比前列酮的制备方法
US9643927B1 (en)	2015-11-17	2017-05-09	Aerie Pharmaceuticals, Inc.	Process for the preparation of kinase inhibitors and intermediates thereof
MX2019002396A (es)	2016-08-31	2019-07-08	Aerie Pharmaceuticals Inc	Composiciones oftalmicas.
JP2020515583A (ja)	2017-03-31	2020-05-28	アエリエファーマシューティカルズインコーポレイテッド	アリールシクロプロピル−アミノ−イソキノリニルアミド化合物
AU2019337703B2 (en)	2018-09-14	2023-02-02	Aerie Pharmaceuticals, Inc.	Aryl cyclopropyl-amino-isoquinolinyl amide compounds

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4011262A (en) *	1972-07-13	1977-03-08	Pfizer Inc.	13,14-Dihydro-15-substituted-ω-pentanorprostaglandins of the two series
IL50310A (en) *	1972-11-08	1977-08-31	Pfizer	Dimethyl ketophosphonates
JPS5720305B2 (fr) *	1973-02-28	1982-04-27
DE2365101A1 (de) *	1973-12-21	1975-07-10	Schering Ag	Neue prostansaeurederivate und verfahren zu ihrer herstellung
DE2460990A1 (de) *	1974-12-21	1976-07-01	Hoechst Ag	Neue prostaglandin-analoga und verfahren zu ihrer herstellung
DE2737808A1 (de) *	1976-08-27	1978-03-16	Pfizer	2-substituierte aryl-heterocyclische omega-pentanorprostaglandine
US4621100A (en) *	1981-09-25	1986-11-04	The Upjohn Company	Treatment of osteoporosis with prostaglandins
DE4024347A1 (de) *	1990-07-27	1992-01-30	Schering Ag	Cyclopentanderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
US5545665A (en) *	1993-12-28	1996-08-13	Allergan	Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
US6169111B1 (en) *	1995-06-07	2001-01-02	Alcon Laboratories, Inc.	Conformationally rigid aryl prostaglandins for use in glaucoma therapy
WO1997023225A1 (fr) *	1995-12-22	1997-07-03	Alcon Laboratories, Inc.	Combinaisons de prostaglandines de type dp et fp destinees a abaisser la pression intraoculaire
US5703108A (en) *	1996-02-28	1997-12-30	Pfizer Inc.	Bone deposition by certain prostaglandin agonists
US5741810A (en) *	1996-02-29	1998-04-21	Allergan	Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents
ES2182088T3 (es) *	1996-06-10	2003-03-01	Sucampo Ag	Antagonista de la endotelina.
ATE221048T1 (de) *	1996-09-17	2002-08-15	Asahi Glass Co Ltd	Fluorierte prostaglandinderivate und medikamente
AU5436198A (en) *	1996-11-12	1998-06-03	Alcon Laboratories, Inc.	11-halo prostaglandins for the treatment of glaucoma or ocular hypertension
AU5258698A (en) *	1996-11-12	1998-06-03	Alcon Laboratories, Inc.	15-ketal prostaglandins for the treatment of glaucoma or ocular hypertension
EP1007028A4 (fr) *	1997-05-09	2002-06-05		Traitement du glaucome a base de 8-iso-prostaglandines

1998
- 1998-09-04 ES ES98944720T patent/ES2253826T3/es not_active Expired - Lifetime
- 1998-09-04 WO PCT/US1998/018340 patent/WO1999012896A1/fr not_active Ceased
- 1998-09-04 PL PL98339213A patent/PL339213A1/xx unknown
- 1998-09-04 TR TR2000/00670T patent/TR200000670T2/xx unknown
- 1998-09-04 HU HU0004436A patent/HUP0004436A3/hu unknown
- 1998-09-04 AT AT98944720T patent/ATE310721T1/de not_active IP Right Cessation
- 1998-09-04 KR KR1020007002512A patent/KR20010023837A/ko not_active Ceased
- 1998-09-04 JP JP2000510708A patent/JP2001515883A/ja not_active Withdrawn
- 1998-09-04 US US09/148,374 patent/US6107338A/en not_active Expired - Lifetime
- 1998-09-04 SK SK336-2000A patent/SK3362000A3/sk unknown
- 1998-09-04 IL IL13479298A patent/IL134792A0/xx unknown
- 1998-09-04 CN CN98808989A patent/CN1269785A/zh active Pending
- 1998-09-04 AU AU92194/98A patent/AU741014B2/en not_active Expired
- 1998-09-04 NZ NZ503736A patent/NZ503736A/en unknown
- 1998-09-04 BR BR9811779-3A patent/BR9811779A/pt not_active IP Right Cessation
- 1998-09-04 EP EP98944720A patent/EP1021402B1/fr not_active Expired - Lifetime
- 1998-09-04 CA CA002303763A patent/CA2303763C/fr not_active Expired - Lifetime
- 1998-09-04 DE DE69832513T patent/DE69832513T2/de not_active Expired - Lifetime
- 1998-09-08 AR ARP980104481A patent/AR017077A1/es unknown
- 1998-09-08 PE PE1998000845A patent/PE123199A1/es not_active Application Discontinuation
- 1998-09-09 ZA ZA988231A patent/ZA988231B/xx unknown
- 1998-09-09 CO CO98051813A patent/CO4970730A1/es unknown
2000
- 2000-03-06 NO NO20001142A patent/NO20001142L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AR017077A1 (es)	2001-08-22
PL339213A1 (en)	2000-12-04
HUP0004436A2 (hu)	2001-05-28
US6107338A (en)	2000-08-22
CA2303763C (fr)	2007-04-24
CN1269785A (zh)	2000-10-11
ATE310721T1 (de)	2005-12-15
NO20001142L (no)	2000-05-04
PE123199A1 (es)	2000-02-02
EP1021402B1 (fr)	2005-11-23
CA2303763A1 (fr)	1999-03-18
NO20001142D0 (no)	2000-03-06
ES2253826T3 (es)	2006-06-01
DE69832513D1 (de)	2005-12-29
AU9219498A (en)	1999-03-29
BR9811779A (pt)	2000-09-12
SK3362000A3 (en)	2000-10-09
AU741014B2 (en)	2001-11-22
WO1999012896A1 (fr)	1999-03-18
ZA988231B (en)	1999-03-09
TR200000670T2 (tr)	2000-11-21
NZ503736A (en)	2002-06-28
HUP0004436A3 (en)	2001-09-28
DE69832513T2 (de)	2006-07-13
JP2001515883A (ja)	2001-09-25
KR20010023837A (ko)	2001-03-26
CO4970730A1 (es)	2000-11-07
EP1021402A1 (fr)	2000-07-26

Publication	Publication Date	Title
ZA988230B (en)	1999-03-09	Aromatic C16-C20-substituted tetrahydro prostaglandins useful as FP agonists
ZA988232B (en)	1999-03-09	Aromatic C16-C20-substituted tetrahydro prostaglandins useful as FP agonists
ZA988231B (en)	1999-03-09	Aromatic C16-C20-substituted tetrahydro prostaglandins useful as FP agonists
AP9801356A0 (en)	1998-12-31	Prostaglandin agonists
DE69941083D1 (en)	2009-08-20	12,13-cyclopropan-epothilonderivate
ZA989537B (en)	1999-04-22	Lubricating composition
IL134108A0 (en)	2001-04-30	Substituted 1,2,3,4-tetrahydronaphthalene derivatives
GB2345916B (en)	2002-07-24	Alkaline solid block composition
ZA974359B (en)	1998-05-12	Microencapsulated compositions.
PL339219A1 (en)	2000-12-04	Substituted 2-pyrolydinones as pkc activators
ZA9811502B (en)	2000-06-15	Novel composition.
ZA200006118B (en)	2002-01-30	Novel composition.
PL338017A1 (en)	2000-09-25	Novel composition
GB9800912D0 (en)	1998-03-11	New composition
GB9701031D0 (en)	1997-03-05	Composition
ZA9710576B (en)	1998-09-16	2-imidazolinylaminoindazole compounds useful as alpha-2-adrenoceptor agonists
ZA200000192B (en)	2000-08-07	Novel composition.
GB9801583D0 (en)	1998-03-25	Anti-snore gargle composition
HK1028976A (en)	2001-03-16	Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
ZA981739B (en)	1999-09-02	Composition.
EG23068A (en)	2004-02-29	Pesticidale composition
ZA991829B (en)	2000-10-11	Novel composition.
GB9611276D0 (en)	1996-07-31	Self indicating composition
GB9806685D0 (en)	1998-05-27	Novel composition
GB9806682D0 (en)	1998-05-27	Novel composition